We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

193 hedge funds and large institutions have $391M invested in ImmunityBio in 2024 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 63 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 21

37% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 46

17% more funds holding

Funds holding: 165 → 193 (+28)

10% more capital invested

Capital invested by funds: $357M → $391M (+$34.1M)

0.91% less ownership

Funds ownership: 9.85% → 8.95% (-0.91%)

31% less call options, than puts

Call options by funds: $24.8M | Put options by funds: $35.9M

Holders
193
Holders Change
+28
Holders Change %
+16.97%
% of All Funds
2.79%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
51
Increased
63
Reduced
46
Closed
21
Calls
$24.8M
Puts
$35.9M
Net Calls
-$11.1M
Net Calls Change
-$13.2M

Top Buyers

1
Jane Street
Jane Street
New York
+$9.28M
2
UBS AM
UBS AM
Illinois
+$9.2M
3
BlackRock
BlackRock
New York
+$6.91M
4
First Trust Advisors
First Trust Advisors
Illinois
+$5.85M
5
AWM
Accurate Wealth Management
Florida
+$3.69M

Top Sellers

1
State Street
State Street
Massachusetts
-$41.7M
2
Invesco
Invesco
Georgia
-$7.95M
3
Citigroup
Citigroup
New York
-$6.72M
4
Rafferty Asset Management
Rafferty Asset Management
New York
-$5.77M
5
PA
Perceptive Advisors
New York
-$5.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
76
ProShare Advisors
Maryland
$382K -$67K -10,160 -14%
Ensign Peak Advisors
77
Ensign Peak Advisors
Utah
$377K – – –
Janus Henderson Group
78
Janus Henderson Group
United Kingdom
$377K -$4.52K -686 -1%
VEA
79
Virtus ETF Advisers
New York
$355K +$230K +34,817 +164%
Handelsbanken Fonder
80
Handelsbanken Fonder
Sweden
$341K +$355K +53,900 New
AQR Capital Management
81
AQR Capital Management
Connecticut
$306K +$196K +29,727 +159%
ETC
82
Exchange Traded Concepts
Oklahoma
$280K -$90.8K -13,770 -24%
New York State Common Retirement Fund
83
New York State Common Retirement Fund
New York
$278K +$63.6K +9,645 +28%
MFG
84
Merit Financial Group
Georgia
$277K +$46 +7 +0%
SA
85
Sanctuary Advisors
Indiana
$271K +$243K +36,840 New
Principal Financial Group
86
Principal Financial Group
Iowa
$261K -$213K -32,247 -44%
Verition Fund Management
87
Verition Fund Management
Connecticut
$257K +$268K +40,663 New
ASRS
88
Arizona State Retirement System
Arizona
$238K +$6.82K +1,035 +3%
SSA
89
Schonfeld Strategic Advisors
New York
$219K +$228K +34,626 New
State Board of Administration of Florida Retirement System
90
State Board of Administration of Florida Retirement System
Florida
$218K +$77.3K +11,720 +52%
BBWA
91
Bell & Brown Wealth Advisors
California
$217K +$659 +100 +0.3%
KAS
92
Kestra Advisory Services
Texas
$215K +$7.91K +1,200 +4%
Zurich Cantonal Bank
93
Zurich Cantonal Bank
Switzerland
$199K -$659 -100 -0.3%
TCM
94
Traynor Capital Management
Pennsylvania
$194K +$54.1K +8,200 +36%
Teacher Retirement System of Texas
95
Teacher Retirement System of Texas
Texas
$187K -$837 -127 -0.4%
RJA
96
Raymond James & Associates
Florida
$181K +$34.3K +5,200 +22%
GCP
97
GSA Capital Partners
United Kingdom
$175K +$182K +27,667 New
KPWS
98
Kestra Private Wealth Services
Texas
$168K +$176K +26,635 New
EFM
99
E Fund Management
China
$167K -$234K -35,464 -57%
BPA
100
Beacon Pointe Advisors
California
$165K – – –
2 3
4
5 6

IBRX Hedge Fund Activity: Q2 2024 in Review

193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q2 2024, worth a combined $391M — up 9.6% from $357M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new IBRX positions and 21 closed out — a net gain of 30 holders — while 63 added to existing stakes and 46 trimmed.

The largest buyer was Jane Street, adding an estimated $9.28M. The largest seller was State Street, cutting an estimated $41.7M.

  • 193 institutional investors held ImmunityBio (IBRX) as of Q2 2024, up from 165 in Q1 2024.
  • Funds reported $391M of ImmunityBio stock for Q2 2024, up 9.6% quarter-over-quarter.
  • 51 funds opened new ImmunityBio positions in Q2 2024 and 21 closed out, a net change of +30 holders.
  • The largest ImmunityBio buyer in Q2 2024 was Jane Street, an estimated $9.28M added.
  • The largest ImmunityBio seller in Q2 2024 was State Street, an estimated $41.7M sold.

Based on aggregated 13F filings for Q2 2024.